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Abstract
Background: Following the recommendation of lung cancer screening in the US, screening committees in several
European countries are reviewing the evidence for implementing national programmes. However, inadequate
participation from high-risk groups poses a potential barrier to its effectiveness. The present study examined
interest in a national lung cancer screening programme and modifiable attitudinal factors that may affect
participation by smokers.
Methods: A population-based survey of English adults (n = 1464; aged 50–70 years) investigated screening
intentions in different invitation scenarios, beliefs about lung cancer, early detection and treatment, worry about
lung cancer risk, and stigma. Data on smoking status and perceived chances of quitting were also collected, but
eligibility for lung screening in the event of a national programme was unknown.
Results: Intentions to be screened were high in all three invitation scenarios for both current (≥ 89%) and former
(≥ 94%) smokers. However, smokers were less likely to agree that early-stage survival is good (43% vs. 53%; OR: 0.64,
0.46–0.88) or be willing to have surgery for an early stage, screen-detected cancer (84% vs. 94%; OR: 0.38, 0.21–0.68),
compared with former smokers. Willingness to have surgery was positively associated with screening intentions;
with absolute differences of 25% and 29%. Worry about lung cancer risk was also most common among smokers
(48%), and one fifth of respondents thought screening smokers was a waste of NHS money.
Conclusions: A national lung cancer screening programme would be well-received in principle. To improve
smokers’ participation, care should be taken to communicate the survival benefits of early-stage diagnosis, address
concerns about surgery, and minimise anxiety and stigma related to lung cancer risk.
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Background
Lung cancer is the leading cause of cancer mortality
worldwide and typically has a bleak prognosis [1]; partly
because early diagnoses are infrequent [2]. Low-dose
computed tomography (LDCT) screening offers a means
of detecting disease early, and was shown by the US Na-
tional Lung Screening Trial (NLST) to reduce the rela-
tive risk of lung cancer mortality by 20%, compared with
chest X-ray, for high-risk adults screened annually over
3 years [3]. Screening is recommended by the US Pre-
ventive Services Task Force (USPSTF) for current
smokers and recent ex-smokers (≤ 15 years since quit-
ting) aged 55 to 80, who have accrued a 30 pack-year
smoking history [4], and is funded by Medicare and Me-
dicaid [5]. Implementation in the UK is under review by
the National Screening Committee [6].
Crucial to the effectiveness of lung cancer screening is
uptake by those at high risk. This will optimise the risk-
benefit ratio as the majority (88%) of deaths prevented
by the NLST were for participants scoring within the
three highest risk quintiles [7]. However, enrolment into
trials has been low, at less than 5% of all those invited in
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the target age range, and biased toward those at lower
risk. Current smoking status and low socioeconomic
position (SEP) have predicted lower attendance across
European and US trials [8–10]; the very factors associ-
ated with increased risk [11].
Surveys carried out in the community find smokers
are more likely to express negative attitudes towards
screening. One US population survey (n = 2001) found
that, compared with former smokers, fewer current
smokers were willing to be screened, believed early de-
tection can increase survival, or anticipated agreeing to
surgery for a screen-detected cancer [12]. In a US survey
of ethnic minority groups, concerns about survival, radi-
ation, financial cost, and the CT scan process predicted
lower screening intentions [13]. More recently, an online
US survey found that high perceived risk, low fear of CT
scans and confidence in their accuracy, and the belief
that early detection can improve prognosis, together pre-
dicted agreement to a LDCT scan [14]. In the UK, a
mixed methods study of lower SEP communities sug-
gested that fatalism about survival, risk, and treatment,
and fear of an expected diagnosis may constitute import-
ant psychosocial deterrents for smokers [15]. Studies of
trial non-participants have also implicated psychological
deterrents, including emotional barriers such as fear,
worry and avoidance [16, 17], fatalistic views and per-
ceptions of low benefit in older age [18], and a lack of
awareness that screening is beneficial for asymptomatic
individuals [18]. Added to this is the potential role of
social factors such as perceived stigmatisation of
smoking [15, 19].
Characteristics of the invitation could also affect
screening uptake. UK screening programmes for breast,
colorectal and cervical cancer organise invitations
through central NHS hubs, but there is good evidence
that GP endorsement [20] and pre-scheduled appoint-
ments [21] improve uptake. The acceptability of these
different invitation scenarios has not been studied for
lung cancer screening.
This study aimed to: i) examine how screening inten-
tions and perceptions of early detection of lung cancer
might differ by smoking status, and ii) measure interest
in, and acceptability of, an NHS lung cancer screening
programme offered in different invitation scenarios.
Methods
A population-based sample of adults aged 50–70 years
took part in the Attitudes, Behaviour and Cancer UK
Survey (ABACUS) in April 2015. This age group was se-
lected to represent individuals who could be eligible for,
or approaching eligibility for, lung cancer screening ac-
cording to the USPSTF criteria [4]. The survey was ad-
ministered within the rolling Omnibus survey [22]
carried out by TNS Research International, which uses
home-based computer-assisted, face-to-face interviews.
Sampling points in England were selected using stratified
random location sampling from the 2011 Census small
area statistics [23], the Postcode Address File and Gov-
ernment Office Regions. At each sampling location,
quotas were set for age, gender, children residing in the
household, and employment status.
Measures
A brief, standardised description of lung cancer screen-
ing was provided and single-item questions were
adapted from existing measures and studies, and piloted
in cognitive interviews (n = 15), and an online survey (n
= 391) prior to this study.
Lung cancer screening intentions
Participants were asked to rate their intention to be
screened following three hypothetical invitation scenar-
ios presented in the same order to all participants: i) an
invitation from a national NHS programme, ii) a GP rec-
ommendation, and iii) an upcoming pre-scheduled ap-
pointment next month. These items were adapted from
the colorectal cancer screening literature [24]. It was
made clear to participants that there is currently no na-
tional lung cancer screening programme in England. Re-
sponses were on a five-point scale for the first two items
(‘yes definitely’, ‘yes probably’, ‘probably not’, ‘definitely
not’, ‘not sure’) and the third item (‘very likely’, ‘likely’, ‘un-
likely’, ‘very unlikely’, ‘not sure’). They were dichotomised
for analysis as ‘yes definitely/probably’ vs. ‘probably/def-
initely not’, and ‘very likely/likely’ vs. ‘very unlikely/un-
likely’. Those answering ‘not sure’ or ‘refused’ on any of
the three items were excluded.
Beliefs about lung cancer survival, early detection and
screening
Two items were taken from the Awareness and Beliefs
about Cancer (ABC) measure [25] concerning survival
from cancer and lung cancer (‘a diagnosis of cancer/lung
cancer is a death sentence’). Response options were on a
four-point scale dichotomised as ‘strongly/tend to agree’
vs. ‘strongly/tend to disagree’ for analysis. Participants
could answer ‘don’t know’ or ‘refused’, but these re-
sponses were excluded from analyses. Participants who
had been diagnosed with cancer (n = 127) were not
asked these questions.
Two items were adapted from Silvestri and colleagues’
US survey [12] to assess beliefs about early-stage lung
cancer: ‘If lung cancer is detected early, what is the per-
son’s chance of surviving?’ (response options on a three-
point scale, dichotomised for analysis as ‘good’ vs. ‘fair/
poor’) and ‘If the screening test found that you had
early-stage lung cancer, would you want to have the rec-
ommended surgery?’ (responses were coded as ‘yes
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definitely/probably’ or ‘probably/definitely not’). ‘Not
sure’, ‘don’t know’ or ‘refused’ responses were excluded.
The acceptability of a screening programme was also
assessed (‘Do you think lung cancer screening is a good
idea?’), as well as opposition against screening targeted
at smokers as an indicator of stigma (‘Do you think that
offering lung cancer screening to smokers is a waste of
NHS money?’) adapted from a validated cancer stigma
scale [26]. Response options were ‘yes’ or ‘no’; ‘don’t
know’ or ‘refused’ responses were excluded.
Worry about lung cancer risk
Frequency of worry about lung cancer risk was mea-
sured by asking, ‘How often do you worry about your
chance of getting lung cancer?’; adapted from Lerman’s
Cancer Worry Scale [27, 28]. Response options were
‘never’, ‘occasionally’, ‘sometimes’, ‘often’, ‘very often’, which
were recoded as ‘never’ vs. ‘at least occasionally’ for ana-
lysis. Respondents who reported worry were asked,
‘Would a clear lung CT scan reassure you?’, to which
they could respond ‘yes’ or ‘no’. ‘Don’t know’ and ‘re-
fused’ responses were excluded from analyses.
Smoking
Smoking status was self-reported using the following
two items from the ABC measure [25]. First, ‘Do you
smoke at all these days, either cigarettes (including
hand-rolled ones), pipes or cigars?’ and second, ‘Have
you ever regularly smoked cigarettes (including hand-
rolled ones), pipes or cigars?’. Former smokers were
therefore defined as individuals who had ever smoked
tobacco regularly. We did not collect data on tobacco
consumption or smoking duration and therefore could
not determine likely screening eligibility status.
Current smokers were asked, ‘How high would you
rate your chances of giving up smoking for good?’ on a
scale adapted from the ‘Motivation To Stop Scale’
(MTSS) [29]. Responses were dichotomised as high (‘ex-
tremely’, ‘very high’, ‘quite high’) vs. low (‘not very high’,
‘low’ or ‘very low’) for analysis.
Demographics
Data on age, gender, ethnicity (White/Not White),
marital status (i) married/cohabiting, ii) single/di-
vorced/separated/widowed), and highest level of
education (i) no formal qualifications, ii) CSEs/O-
levels/equivalent, iii) A-levels/further education/
equivalent, iv) Degree or higher) were collected.
Cancer experience was assessed: ‘Have any friends
or family members that are close to you ever been
diagnosed with cancer?’ to which participants could
answer ‘yes’ or ‘no’.
Analyses
Descriptive frequencies were run to determine absolute
levels of agreement. The associations between smoking
status and agreement with each cancer belief and worry
item were explored using chi-square analyses, and multi-
variable logistic regression, adjusted for demographics
and cancer experience. ‘Don’t know’ (≤ 6.9%) and
‘refused’ (≤ 4.9%) responses were excluded from the
respective analyses.
Chi-square and logistic regression analyses were also
carried out to test for associations between demograph-
ics, smoking status, and screening intentions. Belief
items associated with smoking status were then analysed
to determine their association with screening intentions.
Analyses of screening intentions excluded never smokers
because they would not be eligible for lung cancer
screening. Analyses also excluded cases answering ‘not
sure’ (≤ 2.5%) or ‘refused’ (≤ 2.3%) on any one of the
three intention items (n = 44). Further analyses tested for
demographic differences between this group and the
overall sample.
Finally, exploratory chi-square and logistic regression
analyses tested for associations between quit confidence
and the beliefs, lung cancer worry and screening
intention variables among current smokers only. As
multiple testing increases the type one error rate, a strin-
gent significance threshold was set for the interpretation
of all analyses (p < .01).
Results
Sample characteristics
In total, 1464 participants completed the survey. Partici-
pants were excluded if they did not report their smoking
status (n = 13) or had been diagnosed with lung cancer
(n = 6). The average age of the final sample was 60 years
and there was good representation of different SEP (as
indicated by education level; see Table 1). The majority
were married or cohabiting (62%), and from a White
ethnic background (93%). Experience of cancer through
friends or family was commonly reported (70%).
Twenty two per cent of participants were current
smokers, 26% were former smokers and 52% reported
never having smoked. Current smokers had a lower level
of education, and were less likely to be married (p’s
< .001). Most smokers (62%) rated their chances of stop-
ping smoking as ‘very low’, ‘low’ or ‘not very high’. Be-
yond age and smoking status, participants’ likely
eligibility in the event of a national lung cancer screen-
ing programme was unknown.
Compared with the main sample, current and former
smokers answering ‘don’t know’ or ‘refused’ on the
intention items (n = 44; excluded from the intention
analyses) did not differ in their sociodemographic
characteristics.
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Beliefs about lung cancer survival, early detection and
screening
One in five respondents agreed that a cancer diag-
nosis is a death sentence, but this number doubled
(48%) when the question concerned lung cancer (see
Table 2). In relation to early-stage lung cancer, only
half thought the chances of surviving were good,
but 92% anticipated they would opt for surgery.
Smokers were less likely to agree with these beliefs
compared with former smokers (43% vs. 53%, p = .01;
OR: 0.64, 0.46–0.88, and 84% vs. 94%, p < .001; OR: 0.
38, 0.21–0.68 respectively).
The large majority of participants (97%) thought screening
a good idea, across smoking groups. Using NHS money to
screen smokers was perceived as a waste of NHS money by
21%, but most commonly by former (24%) and never
smokers (22%) compared with current smokers (14%; OR: 0.
45, 0.29–0.69; reference group was former smokers).
While there was a trend towards smokers with a lower
perceived chance of stopping smoking endorsing more
negative beliefs, there were no statistically significant associ-
ations in unadjusted analyses (n= 301; see Table 3). In ad-
justed analyses, smokers who perceived their chance of
quitting as low were less likely to agree that early stage sur-
vival is good compared with those rating their chance of
quitting as high (37% vs. 52%, p= .02; OR: 0.48, 0.29–0.82).
Worry about lung cancer risk
Worrying about risk of lung cancer at least occasionally
was fairly common overall (31%; see Table 2). More
Table 1 Characteristics of the sample by smoking status
All (n = 1445) Never smokers (n = 759) Current smokers (n = 313) Former smokers (n = 373)
Gender, % (n)
Male 49.3 (712) 44.0 (334)b 55.9 (175)b 54.4 (203)b
Female 50.7 (733) 56.0 (425) 44.1 (138) 45.6 (170)
Age, mean (SD) 60.4 (6.3) 60.1 (6.3) 59.2 (6.3) 61.8 (6.1)
Marital status, % (n)
Married/Cohabiting 61.7 (892) 65.3 (496)b 48.2 (151)b 65.7 (245)b
Single/Divorced/Separated/Widowed 38.3 (553) 34.7 (263) 51.8 (162) 34.3 (128)
Ethnicity, % (n)
White 92.9 (1342) 89.3 (678)b 95.5 (299)b 97.9 (365)b
Not White 6.9 (100) 10.4 (79) 4.5 (14) 1.9 (7)
Refused 0.2 (3) 0.3 (2) 0.0 (0) 0.3 (1)
Education level, % (n)
Degree 20.2 (292) 26.2 (199)b 10.2 (32)b 16.4 (61)b
A-levels/further/equivalent 22.6 (327) 24.0 (182) 16.9 (53) 24.7 (92)
CSEs/O-levels/equivalent 28.3 (409) 26.0 (197) 33.5 (105) 28.7 (107)
No formal qualifications 26.1 (377) 21.2 (161) 36.4 (114) 27.3 (102)
Don’t know/Refused 2.8 (40) 2.6 (20) 2.9 (9) 2.9 (11)
Cancer experience, % (n)
Yes (friends/family) 70.2 (1014) 68.8 (522) 69.0 (216) 74.0 (276)
No 28.2 (407) 30.0 (228) 29.1 (91) 23.6 (88)
Don’t know/Refused 1.7 (35) 1.2 (9) 1.9 (6) 2.4 (9)
Quit confidence, % (n)
Extremely high – – 4.2 (13) –
Very high – – 10.2 (32) –
Quite high – – 20.1 (63) –
Not very high – – 21.7 (68) –
Low – – 13.7 (43) –
Very low – – 26.2 (82) –
Don’t know/Refused – – 3.8 (12) –
% totals may not be exactly 100 due to rounding
aχ2, p < .01, b χ2, p < .001
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current smokers reported this worry (48%), compared
with former smokers (29%; OR: 2.38, 1.70–3.33), and
fewer never smokers compared with former smokers
(24% vs. 29%, p < .001); although the latter association
was not statistically significant in adjusted analyses (OR:
0.81, 0.60–1.10). Of the participants who worried about
their risk (n = 429), 90% thought a clear CT scan would
be reassuring, with no association with smoking status.
Lung cancer screening intentions
The large majority of current and former smokers
intended to be screened for lung cancer (see Table 4).
The proportion of intenders was highest if recom-
mended by a GP (93% and 98%, for current and former
smokers respectively), and was similar for the NHS (89%
and 94% for current and former smokers) and upcoming
appointment (89% and 94%) invitation scenarios.
Gender, age, ethnicity, level of education, marital sta-
tus and cancer experience were not associated with
screening intentions. Smoking status was associated with
screening intentions in the GP invitation scenario only.
Fewer current smokers (93%) than former (98%) smokers
intended to participate following a GP recommendation
(p < .01; OR: 0.24, 0.09–0.65). Smokers’ perceived chance
of quitting smoking was not associated with their inten-
tions to be screened.
Perceived survival from early-stage lung cancer was
associated with screening intentions in the GP invita-
tion scenario (see Table 4), with decreased odds for
those thinking survival was poor or fair (94%), com-
pared with good (98%, p < .01; OR: 0.23, 0.08–0.71).
Anticipating not wanting surgery for a screen-
detected early-stage lung cancer predicted a lower
likelihood of intending to be screened in all three sce-
narios. Striking absolute differences in intentions were
observed between the ‘decline’ and ‘pro’ surgery par-
ticipants (26–29%; ORs: 0.04–0.14, p < .001).
Worrying about risk of lung cancer did not affect the
odds of intending to be screened in any of the invitation
scenarios. However, this group was predominantly com-
prised of individuals who worried sometimes or occasion-
ally (85% of the current and former smokers reporting
worry and included in the screening intention analyses).
There were too few cases to subdivide the frequency of
worry by screening intentions for multivariate analysis.
Table 2 Frequencies, chi-square analyses and multivariable logistic regression modelsc, testing the associations between smoking
status, beliefs and worry
All (n = 1445) Former smokers
(reference)
Current smokers Never smokers
% (n) % (n) OR % (n) OR 95% CI % (n) OR 95% CI
A diagnosis of cancer is a death sentence
Strongly/tend to agree (vs. strongly/tend to disagree) 20.5 (257) 16.9a (53) 1.00 26.8a (75) 1.50 0.97–2.29 19.6a (129) 1.29 0.88–1.90
A diagnosis of lung cancer is a death sentence
Strongly/tend to agree (vs. strongly/tend to disagree) 47.6 (582) 46.3 (138) 1.00 53.2 (149) 1.25 0.89–1.76 45.7 (295) 1.01 0.76–1.35
If lung cancer is detected early, what is the person’s chance
of surviving?
Good (vs. fair/poor) 50.8 (689) 53.4 (189) 1.00 43.0 (125) 0.64 0.46–0.88 52.7 (375) 0.95 0.73–1.24
If the screening test found that you had early-stage lung
cancer, would you want to have the recommended surgery?
Yes definitely/probably (vs. definitely/probably not) 91.5 (1209) 93.9b (321) 1.00 84.3b (242) 0.38 0.21–0.68 93.4b (646) 0.99 0.56–1.75
Do you think that lung cancer screening is a good idea?
Yes (vs. no) 97.1 (1354) 97.8 (352) 1.00 96.7 (294) 0.67 0.25–1.77 97.0 (708) 1.10 0.46–2.63
Do you think that offering screening to smokers is a
waste of NHS money?
Yes (vs. no) 20.7 (281) 23.9a (84) 1.00 14.2a (43) 0.45 0.29–0.69 21.9a (154) 0.92 0.67–1.27
How often do you worry about your chance of getting
lung cancer?
Very often to occasionally (vs. never) 30.6 (429) 28.7b (104) 1.00 47.9b (147) 2.38 1.70–3.33 24.4b (178) 0.81 0.60–1.10
Would a clear CT scan reassure you?d
Yes (vs. no) 90.0 (385) 94.2 (97) 1.00 89.7 (130) 0.66 0.24–1.84 87.8 (158) 0.75 0.27–2.05
OR odds ratio, 95% CI 95% confidence interval; n totals may not sum due to missing data
aχ2, p < .01, b χ2, p < .001
cadjusted for demographics and cancer experience
dasked of the subsample of participants reporting lung cancer worry (n = 429)
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The results of unadjusted Fisher’s exact tests suggested
that infrequent worry (i.e. occasionally or sometimes) was
associated with higher screening intentions, whereas fre-
quent worry (i.e. often or very often) was associated with
lower intentions in the NHS invitation scenario (p = .01;
results not reported).
Discussion
This is the first UK population-based study of older
adults to investigate interest in, and perceptions of lung
cancer screening, and to explore their association with
smoking status. Most respondents thought screening a
good idea and the majority of current and former
smokers intended to be screened. However, positive in-
tentions were at odds with frequently fatalistic percep-
tions of lung cancer. Negative beliefs about early-stage
survival and surgery were particularly common among
smokers, and associated with a lower likelihood of
intending to be screened.
Based on intentions alone, these findings suggest that
a UK national screening programme would be accept-
able and well-attended; perhaps especially if recom-
mended by a GP. These findings match the interest
observed among a US population-based survey [12].
However, they are contrary to the low levels of screening
uptake observed in the trial context [10]. The gap be-
tween intentions and behaviour is well-documented for
health precautionary behaviours [30] suggesting these in-
tentions may not be borne out in attendance. Cognitive,
psychosocial or practical factors may subsequently deter-
mine whether intentions are enacted.
Beliefs about the screened disease could be an import-
ant factor. Perceptions of survival from lung cancer were
frequently negative; even when early detection was spe-
cified. This is likely to reflect the poor prognosis lung
cancer currently has, due largely to its late diagnosis. A
deep-rooted lay interpretation might be that outcomes
are universally poor, and there is evidence that early-
stage survival is underestimated [31]. Notably, smokers
Table 3 Frequencies, chi-square analyses, and multivariable logistic regression modelsa, exploring associations between smokers’
perceived chance of quitting, lung cancer beliefs and screening intentions
High quit confidence (reference) Low quit confidence
% (n) OR % (n) OR 95% CI
A diagnosis of cancer is a death sentence
Strongly/tend to agree (vs. strongly/tend to disagree) 25.5 (26) 1.00 28.2 (48) 1.23 0.68–2.24
A diagnosis of lung cancer is a death sentence
Strongly/tend to agree (vs. strongly/tend to disagree) 50.0 (50) 1.00 53.8 (93) 1.14 0.68–1.92
If lung cancer is detected early, what is the person’s chance of surviving?
Good (vs. fair/poor) 51.9 (54) 1.00 37.3 (66) 0.48 0.29–0.82
If the screening test found that you had early-stage lung cancer, would you want to
have the recommended surgery?
Yes definitely/probably (vs. definitely/probably not) 88.0 (88) 1.00 81.3 (143) 0.58 0.27–1.24
Do you think that lung cancer screening is a good idea?
Yes (vs. no) 96.3 (103) 1.00 96.8 (180) 1.11 0.29–4.20
Do you think that offering screening to smokers is a waste of NHS money?
Yes (vs. no) 10.4 (11) 1.00 16.1 (30) 1.62 0.76–3.47
How often do you worry about your chance of getting lung cancer?
Very often to occasionally (vs. never) 48.6 (52) 1.00 47.6 (90) 0.92 0.56–1.51
Would a clear CT scan reassure you?b
Yes (vs. no) 92.2 (47) 1.00 87.6 (78) 0.48 0.13–1.84
NHS invitation
Yes definitely/probably (vs. definitely/probably not) 93.2 (96) 1.00 86.4 (159) 0.55 0.22–1.37
GP recommendation
Yes definitely/probably (vs. definitely/probably not) 94.3 (99) 1.00 92.0 (172) 0.82 0.29–2.29
Appointment next month
Very likely/likely (vs. very unlikely/unlikely) 94.2 (98) 1.00 86.6 (161) 0.46 0.18–1.21
OR odds ratio; 95% CI 95% confidence interval
aadjusted for demographics and cancer experience
basked of the subsample of participants reporting lung cancer worry (n = 142)
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were the most negative. Fewer believed there is a good
chance of surviving early-stage lung cancer, or that they
would undergo surgery for a screen-detected cancer,
mirroring the results of the US survey [12]. Smokers in
this UK sample were more accepting of surgical treat-
ment (84% vs. 56%), which could partly be due to differ-
ences in healthcare provision, as US smokers were more
likely to be deterred by cost. Importantly, those holding
negative beliefs about early-stage survival and surgery
were less likely to intend to be screened, suggesting that
negative perceptions of early detection could undermine
smokers’ screening intentions.
Smokers’ greater pessimism about early-stage lung
cancer may result from more negative experiences of the
disease within their social networks. We adjusted for
previous cancer experience, but did not assess the type.
Alternatively, perhaps smokers in this relatively older
age group have become increasingly fatalistic about their
chances of surviving lung cancer because of their signifi-
cant smoking history, such that screening and treatment
are perceived as offering little promise. These feelings may
be exacerbated by their tobacco dependence, especially if
they feel unable to quit; important because a sizeable pro-
portion of smokers (> 60%) rated their chances of quitting
Table 4 Frequencies, chi-square analyses, and multivariable logistic regression modelsc, exploring associations with lung cancer
screening intentions among current and former smokers
NHS invitationd GP recommendationd Appointment next monthe
Intend % (n) OR 95% CI Intend % (n) OR 95% CI Intend % (n) OR 95% CI
All (n = 642) 91.6 (588) – – 95.8 (615) – – 91.9 (590) – –
Gender
Female 91.6 (261) 1.00 – 95.8 (273) 1.00 – 93.0 (265) 1.00 –
Male 91.6 (327) 1.06 0.59–1.90 95.8 (342) 1.01 0.44–2.33 91.0 (325) 0.78 0.42–1.44
Age – 1.01 0.97–1.06 – 0.96 0.89–1.02 – 0.99 0.94–1.04
Marital status
Married/Cohabiting 92.8 (347) 1.00 – 96.5 (361) 1.00 – 92.8 (347) 1.00 –
Single/Divorced/Widowed 89.9 (241) 0.69 0.26–1.24 94.8 (254) 0.60 0.26–1.39 90.7 (243) 0.69 0.37–1.27
Education level
Degree 88.8 (79) 1.00 96.6 (86) 1.00 – 94.4 (84) 1.00 –
A-levels/further/equivalent 92.9 (130) 1.40 0.54–3.62 96.4 (135) 0.97 0.22–4.26 93.6 (131) 0.86 0.28–2.70
CSEs/O-levels/equivalent 92.5 (184) 1.55 0.64–3.73 96.5 (192) 1.24 0.31–5.04 91.0 (181) 0.68 0.24–1.93
No formal qualifications 91.6 (185) 1.35 0.56–3.24 95.0 (192) 1.04 0.27–4.08 92.1 (186) 0.84 0.29–2.42
Cancer experience
Yes 92.3 (432) 1.00 – 96.4 (451) 1.00 – 93.2 (436) 1.00 –
No 89.9 (151) 0.67 0.36–1.26 94.0 (158) 0.53 0.23–1.23 88.1 (148) 0.48 0.26–0.89
Smoking status
Former 93.7 (328) 1.00 – 98.3 (344)a 1.00 – 94.0 (329) 1.00 –
Current 89.0 (260) 0.67 0.36–1.24 92.8 (271)a 0.24 0.09–0.65 89.4 (261) 0.63 0.33–1.19
Early-stage survival
Good 94.4 (289) 1.00 – 98.4 (301)a 1.00 – 94.4 (289) 1.00 –
Fair/Poor 89.4 (279) 0.46 0.24–0.87 93.9 (293)a 0.23 0.08–0.71 90.7 (283) 0.55 0.28–1.06
Early-stage surgery
Yes definitely/probably 94.3 (512)b 1.00 – 98.7 (536)b 1.00 – 95.4 (518)b 1.00 –
Definitely/probably not 69.4 (43)b 0.14 0.07–0.28 74.2 (46)b 0.04 0.02–0.12 66.1 (41)b 0.09 0.04–0.20
Lung cancer worry
Never 90.5 (364) 1.00 – 95.8 (385) 1.00 – 90.5 (364) 1.00 –
Occasionally to very often 93.7 (223) 1.68 0.88–3.20 96.2 (229) 1.44 0.60–3.46 94.5 (225) 1.80 0.91–3.57
OR odds ratio; 95% CI 95% confidence interval; n totals may not sum due to missing data
aχ2, p < .01; b χ2, p < .001
cadjusted for demographics, cancer experience and smoking status
dpredicting yes definitely/probably vs. probably/definitely not
epredicting very likely/likely vs. very unlikely/unlikely
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as low. While perceived chance of quitting was not associ-
ated with screening intention, this study provided prelim-
inary evidence that lower perceptions of quitting could
foster more negative perceptions of early detection for
lung cancer. This hypothesis deserves further study.
Worry about risk of lung cancer was most prevalent
among smokers; nearly half reported worrying at least
occasionally. Overall, worry did not appear to affect the
likelihood of intending to be screened among current
and former smokers. However, subgroup analyses
showed that frequent worriers actually had lower inten-
tions to be screened, and that infrequent worriers had
the highest intentions in the NHS invitation scenario.
Although preliminary, these results are consistent with
evidence for a curvilinear association [32]. Studies are
needed to measure the constituent components of
smokers’ worry, including frequency, and to explore
their effects on screening participation.
While many respondents worried about their risk of
lung cancer, most believed they would find a clear screen
reassuring. However, this belief may be irrelevant if
screening is expected to lead to a lung cancer diagnosis,
and smokers may therefore be less likely to anticipate re-
assurance. Previous data have shown smokers are more
likely to delay symptomatic help-seeking [33] due to
worry about what the doctor might find [34]. Studies
have also warned that lung cancer screening could
undermine motivation to stop smoking [35]. However,
with the correct communication, screening offers the
opportunity to both assist smoking cessation and raise
symptom awareness. Research is needed which explores
the psychological responses to different screening results
to identify how best to communicate lung cancer risk to
assist positive behaviour change.
Lung cancer screening would be the first cancer
screening programme in the UK to select patients pri-
marily using a behavioural risk factor. In this sample,
nearly one fifth thought screening smokers would be a
waste of NHS money, suggesting that the stigma at-
tached to smoking may adversely affect the acceptability
of a targeted programme. This finding also warns that
the exclusion of never smokers could be a contentious
issue as they can also develop lung cancer, and a quarter
of never smokers reported worrying about this. Oppos-
ition to their exclusion should be addressed by carefully
communicating why LDCT screening is only appropriate
for those at high risk.
This study benefits from a large, population-based
sample, with a higher proportion of smokers (22%) than
was expected for this age group [36] and good represen-
tation of different SEP groups. The measurement of
screening intentions was useful for exploring interest,
but limited conclusions can be made about screening be-
haviour, because the two are not well-correlated [30].
This may have been exacerbated by the fact that the
screening offer was hypothetical and social desirability
bias may have inflated results. Furthermore, asking par-
ticipants about multiple invitation scenarios may have
led them to alter their response for subsequent scenar-
ios relative to the previous scenarios. This method could
have resulted in different invitation preferences com-
pared to asking independent groups about each invita-
tion scenario; although respondents could not alter their
previous responses when interviewed. Alternative
individual-level measures of SEP exist but education has
been shown to be a good indicator in older samples [37].
Single-item, cross-sectional measures were chosen to
minimise participant burden, but may have reduced the
reliability of findings. For the same reason, we did not
collect information on participants’ smoking duration or
history (i.e. pack years) which would have allowed us to
determine their eligibility for lung cancer screening. We
caution that not knowing the likely eligibility status of
participants in our sample may reduce the generalisabil-
ity of these findings to an eligible screening population
in England, should a national screening programme be
recommended.
Conclusions
The introduction of an NHS lung cancer screening
programme appears to be acceptable to older UK adults,
with most current and former smokers intending to be
screened (upwards of 89% and 94%, respectively) espe-
cially if recommended by their GP. Smokers’ greater pes-
simism about survival and treatment for early-stage
cancer could help to explain their lower participation.
Strategies aimed at engaging smokers with screening
should focus on improving perceptions of the curability
of early-stage disease and addressing concerns about
surgical treatment. Communication throughout the
screening process needs to be sensitively devised so that
it is mindful of the existing stigma around smoking, and
the anxiety smokers may have about their increased risk
of lung cancer.
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